3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Melanoma
16
Carcinoma, Renal Cell
13
Carcinoma, Non-Small-Cell Lung
7
Neoplasm Metastasis
6
Clear-cell metastatic renal cell carcinoma
6
Lung Neoplasms
5
Prostatic Neoplasms
4
Myelodysplastic Syndromes
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Penile Neoplasms
2
Nasopharyngeal Carcinoma
2
Meningioma
2
Lymphoma
2
Hematologic Neoplasms
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Interventions
enzalutamide
10
Prednisone
6
Docetaxel
5
Abiraterone Acetate
4
darolutamide
3
olaparib
2
niraparib
2
abiraterone
2
Pluvicto
2
zimberelimab
1
xentuzumab
1
sacituzumab govitecan
1
radium Ra 223 dichloride
1
quemliclustat
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
cabazitaxel
1
TVB-2640
1
Rosuvastatin Calcium
1
Pioglitazone
1
Omeprazole
1
Nivolumab
1
JNJ-64619178
1
JNJ-64264681
1
Ipilimumab
1
Gonadotropin-Releasing Hormone
1
Dexamethasone
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
CTLA-4 Antigen
×
1 year
×
Clear all
NCT04717154
2026-01-06
INSPIRE
Radboud University Medical Center
Phase 2
Completed
69 enrolled